The recent identification of susceptibility genes for schizophrenia, depression and learning and memory dysfunction suggest that psychiatric disorders may be influenced by a small number of genes with multiple actions. This is the first book to investigate the role of growth factors in these disorders, which should provide clues to the underlying biochemical mechanisms. For example, recent studies have substantiated the provocative finding that neuregulin 1 (NRG1)is a candidate gene for schizophrenia. Neuregulin and its receptors, the Erb B tyrosine kinases, are essential for development of the cardiovascular and nervous systems. Lack of NRG1 function may be involved in dysregulation of synaptogenesis and synaptic plasticity in the adult mediated through glutamate receptor function. Polymorphisms for BDNF (brain-derived neurotrophic factor) have also been implicated in the pathogenesis of schizophrenia. BDNF is a prevalent neurotrophic factor that plays an important role in the pathophysiology of depression, bipolar disease and other psychiatric disorders. Other topics addressed in this book include neuroplasticity and neurotrophic factors, signal transduction by neurotrophins, intracellular trafficking of growth factors, trophic factors and cognitive functions, neurotrophins and depression, and pharmacological treatments of schizophrenia.
Tabla de materias
Symposium on Growth factors and psychiatric disorders, held at
the Novartis Foundation, London, 20-22 March 2007.
Editors: Derek J. Chadwick (Organizer) and Jamie
Goode.
This symposium is based on a proposal made by Moses
Chao.
Moses Chao Chair’s introduction.
Daniel C. Javitt Phenomenology, aetiology and treatment
of schizophrenia.
Discussion.
Jonathan Flint, Sagiv Shifman, Marcus Munafo and
Richard Mott Genetic variants in major depression.
Discussion.
Eero Castrén and Tomi Rantamäki
Neurotrophins in depression and antidepressant effects.
Discussion.
Jinbo Fan and Pamela Sklar Genetics of bipolar
disorder: focus on BDNF Val66Met polymorphism.
Discussion.
David A. Talmage Mechanisms of neuregulin action.
Discussion.
General discussion I.
H. Akil, S. J. Evans, C. A. Turner, J. Perez, R. M. Myers, W.
E. Bunney, E. G. Jones, S. J. Watson and other
members of the Pritzker Consortium The fibroblast growth factor
family and mood disorders.
Discussion.
Jay N. Giedd, Rhoshel K. Lenroot, Philip Shaw, Francois
Lalonde, Mark Celano, Samantha White, Julia Tossell, Anjene
Addington and Nitin Gogtay Trajectories of anatomic
brain development as a phenotype.
Discussion.
Bai Lu and Keri Martinowich Cell biology of BDNF
and its relevance to schizophrenia.
Discussion.
Enrico Tongiorgi and Gabriele Baj Functions and
mechanisms of BDNF m RNA trafficking.
Discussion.
Amar Sahay and René Hen Hippocampal
neurogenesis and depression.
Discussion.
Andrés Buonanno, Oh-Bin Kwon, Leqin Yan, Carmen
Gonzalez, Marines Longart, Dax Hoffman and Detlef
Vullhorst Neuregulins and neuronal plasticity: possible
relevance in schizophrenia.
Discussion.
Zhe-Yu Chen, Kevin Bath, Bruce Mc Ewen, Barbara Hempstead
and Francis Lee Impact of genetic variant BDNF (Val66Met) on
brain structure and function.
Discussion.
General discussion II.
D. Malaspina, M. Perrin, K. R. Kleinhaus, M. Opler and
S. Harlap Growth and schizophrenia: aetiology, epidemiology
and epigenetics.
Discussion.
Luiz M. Camargo, Qi Wang and Nicholas J. Brandon
What can we learn from the disrupted in schizophrenia 1
interactome: lessons for target identification and disease
biology?
Discussion.
Michael Spedding and Pierre Gressens Neurotrophins
and cytokines in neuronal plasticity.
Discussion.
Moses Chao Closing remarks.
Index of contributors.
Subject index.
Sobre el autor
The Novartis Foundation is an international scientific and
educational charity which promotes the study and general knowledge
of science and in particular encourages international co-operation
in scientific research.
Chair: MOSES V CHAO, Skirball Institute of Biomolecular
Medicine, New York, USA
Más ebooks del mismo autor / Editor
46.492 Ebooks en esta categoría
